• Cell lysis buffer for WB and IP: Optimizing Native Protein E

  2026-04-21

  Unlock reproducible, high-integrity protein extraction for Western blot and immunoprecipitation—including challenging animal, plant, and microbial samples—using Cell lysis buffer for WB and IP. This non-denaturing, inhibitor-enriched buffer from APExBIO maximizes protein yield and preserves native interactions, streamlining both routine and advanced workflows.

• MRT68921: Redefining ULK1/2 Inhibition in Translational Auto

  2026-04-21

  This article delivers a thought-leadership perspective on leveraging MRT68921, a potent dual ULK1/2 kinase inhibitor, as a transformative tool for translational researchers interrogating autophagy. It integrates recent mechanistic insights, strategic protocol recommendations, and competitive analysis, while advancing the discourse on autophagy modulation beyond standard product literature. The discussion weaves in new findings from fish cell models and highlights opportunities and limitations for cross-species translational impact.

• Propranolol Modulates Burn-Induced Metabolic Stress via Adip

  2026-04-20

  A recent phase II randomized controlled trial demonstrates that propranolol, a non-selective β-adrenergic receptor blocker, normalizes metabolomic and lipidomic signatures in severely burned patients. These findings reveal new mechanistic insights into how propranolol mitigates hypermetabolic stress post-burn, suggesting refined pathways for translational intervention.

• Deferiprone in Iron Stress Research: Beyond Chelation to Mec

  2026-04-20

  Discover how Deferiprone, a 3-hydroxy-1,2-dimethylpyridin-4-one iron chelator, reveals new mechanistic insights into iron stress, apoptosis induction, and enterocyte metabolism. This article uniquely bridges metabolic, inflammatory, and cancer biology research, highlighting advanced applications and protocol considerations.

• Anlotinib Hydrochloride in Functional Angiogenesis Assays

  2026-04-19

  Explore how Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor, redefines functional angiogenesis and endothelial migration assays in cancer research. This article uniquely highlights quantitative protocol parameters and assay design insights that set it apart from existing coverage.

• FGFR and TGFβ/PI3K/AKT Cross Talk Regulates Periostin in HER

  2026-04-18

  Labrèche et al. reveal that periostin expression in HER2-positive breast cancer cells is regulated by a complex cross talk between FGFR, TGFβ, and PI3K/AKT pathways, with implications for tumor aggressiveness. This mechanistic insight highlights new potential avenues for targeted intervention and experimental modeling of gene regulation in oncogenic signaling contexts.

• Halazone (BA1377): Scenario-Driven Solutions for Reliable La

  2026-04-17

  This article delivers a scenario-driven, evidence-based exploration of Halazone (SKU BA1377) for cell viability, cytotoxicity, and neurophysiological assays. Researchers and lab technicians will find practical guidance on protocol optimization, data interpretation, and vendor selection, all rooted in contemporary literature and quantitative performance data. Discover how Halazone enables reproducible, safe, and sensitive workflows in demanding biomedical research contexts.

• Ruxolitinib Phosphate: Deep Mechanisms and Translational Imp

  2026-04-16

  Explore the advanced mechanisms of Ruxolitinib phosphate (INCB018424) as a selective JAK1/JAK2 inhibitor, with new insights into mitochondrial fission and apoptosis in cancer models. This article delivers a distinct, in-depth analysis for researchers targeting the JAK/STAT signaling pathway.

• MK-4827 (Niraparib): Redefining PARP Inhibition with BRCA2 M

  2026-04-15

  Explore MK-4827 (Niraparib), a selective PARP-1/-2 inhibitor, and discover how recent insights into BRCA2 modulation expand the compound's utility in advanced cancer research. This article dives deeper than prior reviews, focusing on assay design and translational impact.

• Optimizing Protease Inhibition with Leupeptin, Microbial (A2

  2026-04-14

  This article addresses common laboratory challenges in protease activity regulation, protein degradation studies, and viral replication inhibition. Using scenario-driven Q&A, it demonstrates how Leupeptin, Microbial (Leupeptin hemisulfate) (SKU A2570) offers reproducibility, validated potency, and workflow practicality for advanced biomedical research.

• Cimetidine (SKU B1557): Reliable H2R Antagonist for Cell Ass

  2026-04-13

  This article provides scenario-driven guidance for researchers using Cimetidine (SKU B1557) in cell viability, proliferation, and BBB permeability studies. Grounded in peer-reviewed literature and supplier specifications, it demonstrates how APExBIO’s high-purity, highly soluble Cimetidine addresses common experimental challenges and supports robust, reproducible workflows in cancer and CNS research.

• PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide):

  2026-04-12

  This article explores real-world laboratory challenges in inflammation and sepsis research, focusing on the reproducibility and specificity of PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide), SKU C4074. Grounded in peer-reviewed evidence and practical optimization, it guides biomedical researchers and lab technicians in selecting and deploying this NF-κB pathway inhibitor for robust cell-based assays.

• Brassinolide in Translational Research: Workflows & Troubles

  2026-04-12

  Brassinolide (24-Epibrassinolide) bridges the gap between plant growth regulation and advanced biomedical research, offering validated protocols for both plant and mammalian systems. This article delivers actionable workflows, troubleshooting insights, and context-driven protocol optimization, uniquely positioning APExBIO’s Brassinolide for high-impact cross-domain studies.

• Latrunculin A: Reversible Inhibitor of Actin Assembly in App

  2026-04-11

  Latrunculin A empowers researchers to dissect actin cytoskeleton dynamics rapidly and reversibly, offering unmatched precision in cell morphology and motility studies. Its validated impact on viral proliferation and cytoskeleton disaggregation makes it an essential tool for advanced cellular research workflows.

• Meropenem Trihydrate: Carbapenem Antibiotic for Resistance S

  2026-04-11

  Meropenem trihydrate from APExBIO empowers advanced antibiotic resistance research with high solubility and robust, reproducible workflows. This guide distills cutting-edge metabolomics insights and practical troubleshooting into actionable protocols for tackling gram-negative and gram-positive infections.

454 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page